Emstopa Limited (10841363) is a private limited with share capital incorporated on 29/06/2017 (9 years old) and registered in sandwich, CT139FF. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Emstopa is a first in class antibody-based reversal agent to treat bleeding caused by tissue plasminogen activator (tpa - activase, alteplase). tpa is a “clot buster” used to remove the blood clots that cause stroke, pulmonary embolism, and myocardial infarction. in the developed world, tpa is most ...